Organisms isolated from adults with Cystic Fibrosis by McManus, Terence E et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Annals of Clinical Microbiology and 
Antimicrobials
Open Access Research
Organisms isolated from adults with Cystic Fibrosis
Terence E McManus*1, Andrew McDowell2, John E Moore2 and 
Stuart J Elborn1
Address: 1Regional Adult Cystic Fibrosis Center, Belfast City Hospital, Belfast, Northern Ireland, BT9 7AB, UK and 2Department of Bacteriology, 
Belfast City Hospital, Belfast, Northern Ireland, BT9 7AB, UK
Email: Terence E McManus* - TerryMcManus@doctors.org.uk; Andrew McDowell - a.mcdowell@qub.ac.uk; 
John E Moore - JeMoore@niphl.dnet.co.uk; Stuart J Elborn - stuart.elborn@bch.n-i.nhs
* Corresponding author    
Cystic FibrosisBacterial InfectionAntibioticsBurkholderia cepacia complexPseudomonas aeruginosa
Abstract
Background: Patients with cystic fibrosis [CF] have frequent pulmonary exacerbations associated
with the isolation of bacterial organisms from sputum samples. It is not clear however, if there are
differences in the types of additional organisms isolated from patients who are infected with
Burkholderia cepacia complex [BCC] or Pseudomonas aerugionsa [PA] in comparison to those who
are not infected with either of these organisms [NI].
Methods: Adult patients attending the regional CF unit were followed over a two year period and
patients were assigned to three groups depending on whether they were known to be chronically
infected with BCC, PA or NI. We compared the numbers and types of organisms which were
isolated in each of these groups.
Results: Information was available on a total of 79 patients; BCC 23, PA 30 and NI 26. Total
numbers of organisms isolated, expressed as median and IQR for each group, [P = 0.045] and
numbers of co-infecting organisms [P = 0.003] were significantly higher in the BCC group compared
to PA, and in the PA group [P < 0.001, p = 0.007 respectively] compared to NI patients. The pattern
of co-infecting organisms was similar in all three groups.
Conclusions: Total numbers of organisms isolated and numbers of co-infecting organisms were
significantly higher in the BCC group compared to PA, and in the PA group compared to NI
patients. Types of co-infecting organisms are similar in all groups of patients.
Introduction
Patients with CF experience frequent exacerbations of
their symptoms; contributing factors include infections
which may be bacterial or viral in nature [1-3]. Exacerba-
tions which are associated with the identification of an
infecting organism are associated with a more rapid
decline in lung function, admission to hospital and earlier
acquisition of P. aeruginosa [PA] [4-6]. It is also known
that those patients who are infected with B. cepacia com-
plex [BCC] have a worse prognosis and often a more rapid
decline in lung function with increased mortality [7]. Pre-
vious investigators examining pathogens infecting the CF
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lung have identified P. aeruginosa, S. aureus, H. influenzae,
S. maltophilia,  A. xylosoxidans and  Aspergillus species as
being important pathogens [1,8].
This study examines the bacterial organisms cultured from
an adult CF population, subdividing them into three
groups; BCC, PA and those who were not infected with
either of these organisms [NI] and to correlate with several
clinical parameters. We hypothesized that those patients
with BCC have more co-infection with other bacteria and
this contributes to the greater morbidity in these patients.
Materials and Methods
Study Design and Eligibility
Data were collected on all patients [>18 years old] attend-
ing the regional adult CF unit at the Belfast City Hospital
for two consecutive years. Sputum specimens were
obtained for each patient at regular clinic attendances
[patients were reviewed at 3 monthly intervals] as well as
twice during hospital admissions. BCC was cultured from
sputum employing selective agar (Columbian Agar Base
cat no: CM331, Oxoid Ltd., Hampshire + 5% Defibrinated
Horse Blood E & O Laboratories, Bonnybridge, Scotland).
All isolates were grouped into cultural phenotypes dis-
playing similar visual characteristics and one colony from
each phenotype identified by API. Sputum samples were
well taken samples following physiotherapy.
Sputum culture results were retrieved from the Bacteriol-
ogy database for all samples submitted over the study
time period. Patients were then divided into three groups
using the following criteria; BCC if there was ever any spu-
tum culture positive for these organisms. PA, if this bacte-
rium was identified on two or more occasions over a
twelve month period, and NI for all other patients who
were not chronically infected with either of these organ-
isms. It was noted as to whether the positive culture con-
sisted of one organism or if there were additional
organisms identified. In the BCC and PA groups, when
more than one organism was identified from a sputum
culture the additional organism [s] where recorded as 'co-
infecting', as where all organisms in cultures of two or
more infecting organisms in the NI group. Co-infecting
organisms were divided into groups; P. aeruginosa,  S.
aureus, H. influenza, S. pneumonia, S. maltophilia and all
other organisms including fungi. The facility to detect res-
piratory viral infection was not available at the time of this
study.
Spirometry [Vitalograph α ,Buckingham, UK] and oxygen
saturation measurements were noted at the start and end
of the study as well as the best measurement for each year.
Weight was recorded at the beginning and end of the two
year period. Other measurements included; smoking his-
tory, use of prophylactic and number of courses of intra-
venous antibiotics and a history of diabetes mellitus.
Statistical Analysis
Statistical analyses were performed using the SPSS version
11 package. The Chi-square test was used to analyse differ-
ences in the sex, smoking status and incidence of diabetes
mellitus between groups. The Kruskal-Wallis and Mann
Whitney test were used to compare antibiotic use and
organisms isolated across groups. Lung Function and
Oxygen saturation means were compared by one-way
analysis of variance followed by the Student-Newman-
Keuls method. A probability (P) value of less than 0.05
was considered statistically significant.
Results
Information was available on a total of 79 patients, mean
[Standard Deviation] age 26 [7.9] years. Numbers in each
group were as follows; BCC 23 [2 Burkholderia multivorans,
21 Burkholderia cenocepacia, all ET -12], PA 30 and NI 26.
Those patients in the BCC group had a mean duration of
infection of 67 months. There was no difference in the sex
distribution between the groups, P = 0.18. There were a
total of 10 [12.7%] patients with diabetes, but they had
no relationship with the groupings [P = 0.19]. There were
significantly more smokers in the BCC group [P = 0.005]
in comparison to PA and NI. Prophylactic antibiotic use
was similar throughout all groups, P = 0.14. Intravenous
antibiotic use was similar in the BCC and PA patient
groups but significantly higher compared to NI [P <
0.001], table 1. There was no difference in oral antibiotic
use between the groups. Those patients in the BCC group
had a significant reduction in their weight compared to
the PA and NI groups (P < 0.05); there was an average
weight loss of 1.1 Kg. Patients in the PA and NI groups
gained weight, 0.69 ± 2.5 and 1.82 ± 2.7 kilograms
respectively.
The changes between the best FEV1 measured each year,
the change in FEV1 between the start and end were not sig-
nificant between the groups. Oxygen saturation measured
at the end of the study tended to be lower in the BCC and
PA groups when compared to the NI group; however there
were no significant differences for the best SaO2 values for
each year.
Median and interquartile ranges of organism numbers
[total numbers and numbers of co-infecting organisms]
and specimen numbers in each group are shown in table
2 along with details of the types of co-infecting organisms.
Total numbers of organisms isolated, that is the number
of isolates of different organisms, [P = 0.045] and num-
bers of co-infecting organisms [P = 0.003] were signifi-
cantly higher in the BCC group compared to PA and in the
PA group [P < 0.001, P = 0.007] compared to NI. TotalAnnals of Clinical Microbiology and Antimicrobials 2004, 3:26 http://www.ann-clinmicrob.com/content/3/1/26
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numbers of positive sputum cultures were greater in both
the BCC and PA groups in comparison to NI [P < 0.0001].
The pattern of co-infecting organisms, Staphylococcus
aureus, Haemophilus influenzae, Streptococcus pneumoniae,
Stenotrophomonas maltophilia, was similar in all three
groups except for P. aeruginosa being more frequently
detected in the BCC group in comparison to NI [p <
0.0001].
Discussion
This study identified individuals with BCC and PA more
frequently require courses of IV antibiotic therapy in com-
parison to CF adults in whom neither pathogen was iden-
tified [NI]. This is in keeping with previous findings in
which patients colonized with BCC [9,10] and PA [11,12]
were noted to have a more rapid decline in health status
with an associated increased number of hospital admis-
sions for treatment of infective exacerbations. Prophylac-
tic antibiotic use was found to be similar in all groups,
however their role and the optimal duration of treatment
of CF patients remains controversial [13].
The BCC group were also noted to have significant weight
loss over the study period, again this has been shown to
act as an independent predictor of survival in this group
[14]. No significant differences were demonstrated
between weight change in the PA and NI groups; it may be
that a longer period of study is required to detect signifi-
cant differences.
On comparison of PA and BCC patients to those in the NI
group, investigators have previously demonstrated higher
morbidity [10,12]. In this study we have found higher
total numbers of positive sputum specimens, total num-
bers of organisms and increased numbers of co-infecting
organisms in the BCC and PA groups in comparison to NI
[P < 0.01]. To our knowledge this is the first paper to relate
bacterial colonization to the numbers and types of coin-
fecting organisms isolated during exacerbations. Patients
infected with BCC are known to have elevated lung
inflammation[15] with an accelerated rate of lung func-
tion decline[9], this in part may be due to BCC lipopoly-
saccharides mediated neutrophil recruitment and
Table 1: Use of oral and intravenous antibiotics; median [Interquartile Range].
Antibiotic Courses Patient Group
BCC PA NI
No. of Patients 23 30 26
Oral 0 [0–2.0] 1 [0–2.0] 1 [0–2.3]
Intravenous 3 [1.0–11.0] 3 [2.0–5.0] 0 [0–2.0]
Table 2: Median [Interquartile Range] of numbers of sputum specimens, total numbers of organisms and numbers of co-infecting 
organisms [per patient] in each group. Mean ± SD numbers of individual co-infecting organisms isolated per patient in each group.
Measurement Patient Group
BCC PA NI
No. of Patients 23 30 26
Total No. of Specimens / patient 24 [9.0–59.0] 19.5 [5.5–34.5] 0 [0–9.8]
Total No. of Organisms / patient † 32 [16.0–79.0] 24 [7.8–46.3] 0 [0–11.3]
No. of Co-infecting Organisms / patient ‡ 15 [8.0–20.0] 3.5 [0.8–11.3] 0 [0–4.3]
P. aeruginosa co-infection 14.4 ± 19.7 - 0.1 ± 0.3
S. aureus co-infection 3.6 ± 4.8 2.0 ± 4.1 3.7 ± 7.5
H. influenza co-infection 1.8 ± 2.9 0.7 ± 1.6 1.1 ± 3.1
S. pneumonia co-infection 0.6 ± 1.2 0.2 ± 0.5 0.4 ± 1.0
S. maltophilia co-infection 0.9 ± 1.5 2.6 ± 6.6 1.7 ± 6.3
Other organism co-infection 1.4 ± 1.9 3.1 ± 5.9 1.7 ± 3.2
† Total number of different bacterial organisms isolated in that group of patients during the study period.
‡ Number different bacterial organisms isolated excluding those isolates for BCC or PA in those patients who are colonized with these bacteria.Annals of Clinical Microbiology and Antimicrobials 2004, 3:26 http://www.ann-clinmicrob.com/content/3/1/26
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subsequent respiratory burst response [16]. This pro-
inflammatory status may predispose individuals to
increased morbidity and co-infection. BCC infection has
also been linked to a compromised host response [17]
and combined with a poor nutritional status [14]
increases the likelihood of respiratory tract infection in
these patients. In this study the types of organisms iso-
lated did not differ significantly between the groups,
organisms corresponding to those found on previous
studies [1]. It should be borne in mind that these findings
relate to the adult CF population in Northern Ireland
which is unique in that the majority of B. cepacia complex
positive patients are colonized with a single strain (B. cen-
ocepacia ET12).
It is well documented that CF patients experience a more
rapid decline in their lung function [18]. However, no sig-
nificant changes in lung function were seen between the
start and end of the study and on comparison between
groups. It is possible that this is due to the relatively small
group numbers or that a longer follow-up period is
required. The prevalence of diabetes mellitus amongst the
groups was similar; its presence has recently been associ-
ated with a more rapid decline in lung function in CF
patients [6]. Surprisingly, the incidence of smoking was
highest amongst those with more severe disease in the
BCC group.
Investigators have shown evidence of this type of risk tak-
ing behaviour in these patients, however it is actually
lower when compared than their peer group [19]. This
emphasizes the importance of addressing relevant risk fac-
tors and behaviour amongst these patients.
Conclusion
Patients with BCC and PA infection have a similar use of
antibiotics. Total numbers of organisms isolated and
numbers of co-infecting organisms are significantly
higher in the BCC group compared to PA, and in the PA
group compared to NI patients. Types of co-infecting
organisms are similar in all groups of patients.
Abbreviations
BCC Burkholderia cepacia complex
CF Cystic fibrosis
FEV1 Forced expiratory volume in one second
NI 'Neither Isolated' group
No. Number
P Probability
PA Pseudomonas aeruginosa
SAO2 Oxygen Saturation
SD Standard Deviation
SE Standard Error
SPSS Statistical Package for the Social Sciences
SPECIAL CHARACTERS:
< Less than
α Alpha
Competing Interests
The authors' declare that they have no competing
interests.
Authors' Contributions
TMcM
Collected data relating to the study and drafted the paper.
AMcD
Participated in the analysis of clinical specimens and con-
tributed to the manuscript content.
JEM
Participated in the study design and coordination.
JSE
Conceived of the study and participated in its design and
coordination.
All authors read and approved the final manuscript
Acknowledgements
Dr Chris Patterson [Department Of Epidemiology, Queens University Bel-
fast] performed the statistical analysis of all data.
References
1. Govan JR, Nelson JW: Microbiology of lung infection in cystic
fibrosis. Br Med Bull 1992, 48:912-930.
2. Ong EL, Ellis ME, Webb AK, Neal KR, Dodd M, Caul EO, Burgess S:
Infective respiratory exacerbations in young adults with
cystic fibrosis: role of viruses and atypical microorganisms.
Thorax 1989, 44:739-742.
3. Rubio TT: Infection in patients with cystic fibrosis. Am J Med
1986, 81:73-77.
4. Armstrong D, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A,
Phelan PD: Severe viral respiratory infections in infants with
cystic fibrosis. Pediatr Pulmonol 1998, 26:371-379.
5. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso
FJ: Risk factors for initial acquisition of Pseudomonas aerugi-
nosa in children with cystic fibrosis identified by newborn
screening. Pediatr Pulmonol 2003, 35:257-262.
6. Schaedel C, de MI, Hjelte L, Johannesson M, Kornfalt R, Lindblad A,
Strandvik B, Wahlgren L, Holmberg L: Predictors of deterioration
of lung function in cystic fibrosis.  Pediatr Pulmonol 2002,
33:483-491.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Annals of Clinical Microbiology and Antimicrobials 2004, 3:26 http://www.ann-clinmicrob.com/content/3/1/26
Page 5 of 5
(page number not for citation purposes)
7. Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan
PH, Morgan WM, Carson LA, Martone WJ, Jason JM, .: Pseu-
domonas cepacia colonization in patients with cystic fibrosis:
risk factors and clinical outcome. J Pediatr 1985, 107:382-387.
8. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ram-
sey BW, Clausen CR: Microbiology of sputum from patients at
cystic fibrosis centers in the United States. Clin Infect Dis 1998,
27:158-163.
9. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ: Out-
come of Burkholderia cepacia colonisation in an adult cystic
fibrosis centre. Thorax 2002, 57:142-145.
10. Muhdi K, Edenborough FP, Gumery L, O'Hickey S, Smith EG, Smith
DL, Stableforth DE: Outcome for patients colonised with Bur-
kholderia cepacia in a Birmingham adult cystic fibrosis clinic
and the end of an epidemic. Thorax 1996, 51:374-377.
11. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robert-
son CF, Grimwood K: Clinical outcome after early Pseu-
domonas aeruginosa infection in cystic fibrosis. J Pediatr 2001,
138:699-704.
12. Rosenstein BJ, Zeitlin PL: Prognosis in cystic fibrosis. Curr Opin
Pulm Med 1995, 1:444-449.
13. Smyth A, Walters S: Prophylactic antibiotics for cystic fibrosis.
Cochrane Database Syst Rev 2001:CD001912.
14. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ,
Hodson ME, Anker SD, Henein MY: Wasting as an independent
predictor of mortality in patients with cystic fibrosis. Thorax
2001, 56:746-750.
15. Hendry J, Elborn JS, Nixon L, Shale DJ, Webb AK: Cystic fibrosis:
inflammatory response to infection with Burkholderia cepa-
cia and Pseudomonas aeruginosa. Eur Respir J 1999, 14:435-438.
16. Hughes JE, Stewart J, Barclay GR, Govan JR: Priming of neutrophil
respiratory burst activity by lipopolysaccharide from Bur-
kholderia cepacia. Infect Immun 1997, 65:4281-4287.
17. Hutchison ML, Poxton IR, Govan JR: Burkholderia cepacia pro-
duces a hemolysin that is capable of inducing apoptosis and
degranulation of mammalian phagocytes. Infect Immun 1998,
66:2033-2039.
18. Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A: Fifteen-
year follow-up of pulmonary function in individuals hetero-
zygous for the cystic fibrosis phenylalanine-508 deletion. J
Allergy Clin Immunol 2001, 107:818-823.
19. Britto MT, Garrett JM, Dugliss MA, Daeschner CWJ, Johnson CA,
Leigh MW, Majure JM, Schultz WH, Konrad TR: Risky behavior in
teens with cystic fibrosis or sickle cell disease: a multicenter
study. Pediatrics 1998, 101:250-256.